Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an "In Vivo" Model of Neurotoxicity

Int J Mol Sci. 2024 Feb 10;25(4):2142. doi: 10.3390/ijms25042142.

Abstract

Chronic exposure to manganese (Mn) leads to its accumulation in the central nervous system (CNS) and neurotoxicity with not well-known mechanisms. We investigated the involvement of matrix metalloproteinase (MMP)-2 and -9 in Mn neurotoxicity in an in vivo model of rats treated through an intraperitoneal injection, for 4 weeks, with 50 mg/kg of MnCl2 in the presence or in the absence of 30 mg/kg of resveratrol (RSV). A loss of weight was observed in Mn-treated rats compared with untreated and RSV-treated rats. A progressive recovery of body weight was detected in rats co-treated with Mn and RSV. The analysis of brain homogenates indicated that RSV counteracted the Mn-induced increase in MMP-9 levels and reactive oxygen species production as well as the Mn-induced decrease in superoxide dismutase activity and glutathione content. In conclusion, Mn exposure, resulting in MMP-9 induction with mechanisms related to oxidative stress, represents a risk factor for the development of CNS diseases.

Keywords: central nervous system; manganese; matrix metalloproteinases; neurotoxicity; oxidative stress; resveratrol.

MeSH terms

  • Animals
  • Manganese / toxicity
  • Matrix Metalloproteinase 9 / drug effects
  • Neuroprotective Agents* / pharmacology
  • Neurotoxicity Syndromes* / drug therapy
  • Neurotoxicity Syndromes* / etiology
  • Neurotoxicity Syndromes* / prevention & control
  • Oxidative Stress
  • Rats
  • Resveratrol* / pharmacology

Substances

  • Manganese
  • Matrix Metalloproteinase 9
  • Neuroprotective Agents
  • Resveratrol

Grants and funding

This research received no external funding.